Merck Tbk (Indonesia) Management Evaluation
MERK Stock | IDR 3,430 10.00 0.29% |
Merck Tbk employs about 393 people. The company is managed by 13 executives with a total tenure of roughly 81 years, averaging almost 6.0 years of service per executive, having 30.23 employees per reported executive. Inspection of Merck Tbk's management performance can provide insight into the company performance.
Mei Tang President President Commissioner |
Martin Feulner President President Director |
Merck |
Merck Tbk Management Team Effectiveness
The company has return on total asset (ROA) of 0.1573 % which means that it generated a profit of $0.1573 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2334 %, meaning that it generated $0.2334 on every $100 dollars invested by stockholders. Merck Tbk's management efficiency ratios could be used to measure how well Merck Tbk manages its routine affairs as well as how well it operates its assets and liabilities.Merck Tbk Workforce Comparison
Merck Tbk is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 28,765. Merck Tbk claims roughly 393 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21. Merck Tbk Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Merck Tbk Price Series Summation is a cross summation of Merck Tbk price series and its benchmark/peer.
Merck Tbk Notable Stakeholders
A Merck Tbk stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Merck Tbk often face trade-offs trying to please all of them. Merck Tbk's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Merck Tbk's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mei Tang | President Commissioner | Profile | |
Martin Feulner | President Director | Profile | |
Arryo Wachjuwidajat | Independent Director, Plant Director | Profile | |
Bambang Nurcahyo | Finance Director | Profile | |
Evie Yulin | Biopharma Director | Profile | |
Melisa Sandrianti | Corporate Secretary | Profile | |
Parulian Simanjuntak | Independent Commissioner | Profile | |
Aquira Moeladi | Human Head | Profile | |
Pachita Ramadhani | Head Mang | Profile | |
Rinita Daniati | Head Legal | Profile | |
Eduan Tjong | Supply Mang | Profile | |
Miranda Andamsari | Compliance Officer | Profile | |
Eza Evariza | Accounting Mang | Profile |
About Merck Tbk Management Performance
The success or failure of an entity such as Merck Tbk often depends on how effective the management is. Merck Tbk management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Merck management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Merck management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. Merck Tbk operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 405 people.
Merck Tbk Workforce Analysis
Traditionally, organizations such as Merck Tbk use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Merck Tbk within its industry.Merck Tbk Manpower Efficiency
Return on Merck Tbk Manpower
Revenue Per Employee | 2.7B | |
Revenue Per Executive | 81.9B | |
Net Income Per Employee | 335M | |
Net Income Per Executive | 10.1B |
Other Information on Investing in Merck Stock
Merck Tbk financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck Tbk security.